文献速递眼整形与眼眶

Wnt信号通路抑制Graves眼病眼眶成纤维细胞脂肪生成

Wnt signalling inhibits adipogenesis in orbital fibroblasts from patients with Graves' orbitopathy.
PubMed 文献 · Br J Ophthalmol · 2021-06-30

该研究利用Graves眼病(GO)与非GO患者来源的原代眼眶成纤维细胞(OF),比较Wnt信号通路相关蛋白表达并观察其对脂肪分化的影响。结果发现GO来源OF中β-catenin与cyclin D1降低、磷酸化β-catenin升高,Wnt刺激剂可剂量依赖性减少PPARγ、C/EBPα、C/EBPβ并抑制GO OF脂肪生成。提示Wnt信号通路抑制GO眼眶成纤维细胞脂肪生成。

要点

  • GO来源OF中β-catenin与cyclin D1显著降低、磷酸化β-catenin显著升高。
  • Wnt刺激剂剂量依赖性减少PPARγ、C/EBPα、C/EBPβ并抑制GO OF脂肪生成。
  • Wnt信号通路可能成为GO治疗策略的潜在靶点,尚需进一步研究。

核心结论

  • Wnt信号通路抑制GO与非GO来源眼眶成纤维细胞的脂肪生成。

研究设计与样本

  • 获取GO与非GO参与者的眼眶脂肪进行原代眼眶成纤维细胞培养。
  • 比较GO与非GO来源OF中Wnt5a、Wnt10b、β-catenin、磷酸化β-catenin与cyclin D1表达。
  • 在GO与非GO来源OF脂肪分化过程中检测上述表达,并研究Wnt信号刺激剂与抑制剂对脂肪生成的影响。

主要发现

  • Western blotting显示GO来源OF较非GO来源OF的β-catenin与cyclin D1显著降低、磷酸化β-catenin显著升高(p<0.05)。
  • OF中Wnt5a、Wnt10b、β-catenin与cyclin D1表达在诱导脂肪分化第0天最高,随后逐渐下降。
  • Wnt刺激剂处理的OF中PPARγ、C/EBPα与C/EBPβ表达呈剂量依赖性降低。
  • 油红O染色证实Wnt刺激剂抑制GO来源OF的脂肪生成。

关键数值与推荐

  • GO来源OF较非GO来源OF的β-catenin与cyclin D1显著降低、磷酸化β-catenin显著升高(p<0.05)。
  • Wnt刺激剂使OF中PPARγ、C/EBPα与C/EBPβ表达呈剂量依赖性降低。
  • 油红O染色证实Wnt刺激剂抑制GO来源OF脂肪生成。

临床怎么用

  • 本研究为体外细胞实验,提示Wnt信号通路可能作为GO脂肪生成的治疗靶点,尚需进一步研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND/AIMS: To investigate the role of Wnt signalling in adipogenesis using an in vitro model of Graves' orbitopathy (GO). METHODS: Orbital fat was obtained from patients with GO and non-GO participants for primary orbital fibroblast (OF) culture. Expression levels of Wnt5a, Wnt10b, β-catenin, phospho-β-catenin and cyclin D1 were compared between GO and non-GO OFs. These expression levels were also determined during adipogenesis of GO and non-GO OFs. The effects of a stimulator and inhibitor of Wnt signalling on adipogenesis of GO and non-GO OFs were investigated. RESULTS: Western blotting analysis showed significant reductions in β-catenin and cyclin D1 and significant enhancement of phospho-β-catenin in OFs from patients with GO, compared with OFs from non-GO participants (p<0.05). Expression of Wnt5a, Wnt10b, β-catenin and cyclin D1 in OFs was highest on day 0, and then gradually declined after induction of adipogenic differentiation. The expression levels of PPARγ, C/EBPα and C/EBPβ were reduced in Wnt stimulator-treated OFs in a dose-dependent manner. Oil red O staining confirmed that a stimulator of Wnt inhibited adipogenesis in GO OFs. CONCLUSION: These results indicate that Wnt signalling inhibits adipogenesis in OFs from patients with GO and non-GO participants. Further studies are required to examine the potential of Wnt signalling as a target for therapeutic strategies.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Jung SJ, Choi YJ, Park TK, et al. Wnt signalling inhibits adipogenesis in orbital fibroblasts from patients with Graves' orbitopathy. Br J Ophthalmol. 2021. PMID: 34193409. doi:10.1136/bjophthalmol-2020-316898

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。